These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. BRL 34915 (Cromakalim) stimulation of 42K efflux from rabbit arteries is modulated by calcium. Post JM; Smith JM; Jones AW J Pharmacol Exp Ther; 1989 Aug; 250(2):591-7. PubMed ID: 2760842 [TBL] [Abstract][Full Text] [Related]
4. Effects of the antihypertensive agent, cicletanine, on noradrenaline release and vasoconstriction in perfused mesenteric artery of SHR. Nasa Y; Yoshida H; Urata M; Uchibayashi K; Tsunoda Y; Kamigata K; Takeo S Br J Pharmacol; 1998 Feb; 123(3):427-34. PubMed ID: 9504383 [TBL] [Abstract][Full Text] [Related]
5. Effects of putative K+ channel activator BRL-34915 on arterial contraction and 86Rb efflux. Cox RH J Pharmacol Exp Ther; 1990 Jan; 252(1):51-9. PubMed ID: 2299602 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of novel, peripherally selective chromanyl imidazolethione-based inhibitors of dopamine beta-hydroxylase. Beliaev A; Learmonth DA; Soares-da-Silva P J Med Chem; 2006 Feb; 49(3):1191-7. PubMed ID: 16451083 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological properties of 2-(2-chloro-p-toluidino)-2-imidazoline-nitrate (tolonidine), a new antihypertensive agent. III. Action on the secretions of the digestive tract and on the central nervous system, acute toxicity. Cosnier D; Hache J; Labrid C; Streichenberger G Arzneimittelforschung; 1975; 25(12):1926-33. PubMed ID: 3186 [TBL] [Abstract][Full Text] [Related]
9. Antihypertensive and haemodynamic properties of the potassium channel activating (-) enantiomer of cromakalim in animal models. Clapham JC; Hamilton TC; Longman SD; Buckingham RE; Campbell CA; Ilsley GL; Gout B Arzneimittelforschung; 1991 Apr; 41(4):385-91. PubMed ID: 1907150 [TBL] [Abstract][Full Text] [Related]
10. Norepinephrine depleting and antihypertensive effect of 4-methoxy-3,5-dihydroxyphenylalanine. Thoenen H; Gerold M; Haefely W; Huerlimann A Experientia; 1968 Feb; 24(2):158-9. PubMed ID: 4384506 [No Abstract] [Full Text] [Related]
11. Comparison of the relaxing effects of cicletanine and cromakalim on vascular smooth muscle. Deitmer P; Golenhofen K; Noack T J Cardiovasc Pharmacol; 1992 Jul; 20(1):35-42. PubMed ID: 1383629 [TBL] [Abstract][Full Text] [Related]
12. Proceedings: Influence of morphine on the release of noradrenaline from brain slices. Montel H; Weber F Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R67. PubMed ID: 4276618 [No Abstract] [Full Text] [Related]
13. Studies on the mechanism of action of the antihypertensive agent cicletanine. Castro A; Parra L; Fuentes JA Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():51-4. PubMed ID: 2514669 [TBL] [Abstract][Full Text] [Related]
14. [Noradrenaline in the central nervous system (animal experiments in basic research and pharmacotherapeutic research)]. Starke K Arzneimittelforschung; 1981; Suppl 27():11-4. PubMed ID: 6118156 [No Abstract] [Full Text] [Related]
15. The synthesis and biological evaluation of a range of novel functionalized benzopyrans as potential potassium channel activators. Tyrrell E; Tesfa KH; Greenwood I; Mann A Bioorg Med Chem Lett; 2008 Feb; 18(3):1237-40. PubMed ID: 18191566 [TBL] [Abstract][Full Text] [Related]
16. [Effect of 2-amino-4,5,6,7-tetrahydro-5-propyl-thiazole(5,4-c)pyridine, an antihypertensive and sedative substance, on the noradrenaline storage in the heart of guinea pigs]. Honjo T; Engelhardt G Arzneimittelforschung; 1970 Jun; 20(6):845-50. PubMed ID: 5468901 [No Abstract] [Full Text] [Related]
17. [Effect of nifedipine on vascular reactivity: study on the isolated and perfused rat kidney]. Jover B; Caselas D; Dupont M; Mimran A Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():41-3. PubMed ID: 6810827 [No Abstract] [Full Text] [Related]
18. Further evidence for a peripheral sympathicolytic action of the antihypertensive cicletanine in rats. Castro A; Hernando F; Parra L; Puerro M; Aleixandre A; Fuentes JA Drugs Exp Clin Res; 1995; 21(1):29-36. PubMed ID: 7796710 [TBL] [Abstract][Full Text] [Related]
19. [Synthesis and bioactivity of some 3,4-diacyloxybenzopyrans]. Yan Z; Huang WL; Peng SX; Hua WY Yao Xue Xue Bao; 1997; 32(2):97-105. PubMed ID: 11243208 [TBL] [Abstract][Full Text] [Related]
20. Studies on the mechanism of action by which 5H-[1]-benzopyrano-[2,3,-b]-pyridin-5-ol (AH 6696) inhibits gastric acid secretion [proceedings]. Ashby P; Curwain BP; Daly MJ; McIsaac RL Br J Pharmacol; 1976 Jul; 57(3):440P-441P. PubMed ID: 974337 [No Abstract] [Full Text] [Related] [Next] [New Search]